Loading
Cancer, Lipids, and Metabolism / Immune Cells in Cancer / Cancer Research and Treatments · Journal article
Experimental & Molecular Medicine · August 18, 2026
Raises a question worth testing. It does not answer one.
This narrative review synthesizes mechanistic and emerging evidence on lipid metabolism's role in tumour microenvironment biology and anti-tumour immunity, proposing lipid metabolism as a therapeutic target. The work is conceptual and integrative rather than providing empirical validation of a specific intervention or clinical outcome.
Journal article.
Tumours create a hypoglycaemic, metabolically restrictive niche that drives both cancer cells and infiltrating immune cells to rely on lipid uptake, storage and catabolism for survival and function. Dietary lipid composition, beyond total fat intake alone, profoundly influences tumour progression and anti-tumour immunity. Lipids function as both metabolic substrates and signalling mediators within the tumour microenvironment.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies lipid metabolism as a conceptual frontier for cancer therapy development and highlights the potential importance of dietary lipid composition in modulating anti-tumour immunity; however, readers should treat these as mechanistic insights and emerging hypotheses requiring empirical validation rather than as established clinical guidance.
This is a narrative review integrating mechanistic concepts and emerging evidence rather than reporting original empirical findings or clinical outcomes; it raises questions about lipid metabolism as a therapeutic target rather than answering them with trial data.
This review identifies lipid metabolism as a conceptual frontier for cancer therapy development and highlights the potential importance of dietary lipid composition in modulating anti-tumour immunity; however, readers should treat these as mechanistic insights and emerging hypotheses requiring empirical validation rather than as established clinical guidance.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Abstract The tumour microenvironment (TME) consists of a complex ecosystem of tumour cells, stromal elements, extracellular matrix, fibroblasts and diverse immune-cell populations. Although traditional cancer therapies have primarily focused on eliminating tumour cells, subsequent advances highlighted the importance of modulating immune cells within the TME to enhance anti-tumour immunity. More recently, a major conceptual shift has emerged: targeting nutrient metabolism as a therapeutic strategy. Because tumours create a hypoglycaemic, metabolically restrictive niche, both cancer cells and infiltrating immune cells increasingly rely on lipid uptake, storage and catabolism to sustain their survival and function. This metabolic dependency reveals new vulnerabilities that can be exploited for cancer therapy. In this review, we integrate fundamental concepts of lipid metabolism with recent mechanistic discoveries that define how lipids shape cellular behaviours within the TME, emphasizing the dual roles of lipids as both metabolic substrates and signalling mediators. We also highlight emerging evidence demonstrating that dietary lipid composition — beyond total fat intake — profoundly influences tumour progression and anti-tumour immunity. Together, these insights position lipid metabolism as a critical regulator of tumour biology and an attractive target for next-generation cancer therapies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.